Literature DB >> 8756655

A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis.

P Friedlander1, Y Haupt, C Prives, M Oren.   

Abstract

Human wild-type (wt) p53 can induce apoptosis in transiently transfected H1299 cells maintained at 37 degrees C, whereas tumor-derived mutant forms of p53 (with the mutation Ala-143, His-175, or Trp-248) fail to do so. At 37 degrees C, p53 with a mutation to Ala at amino acid 143 (p53Ala143) was transcriptionally inactive. However, at 32 degrees C, p53Ala143 strongly activated transcription from several physiologically relevant p53-responsive promoters, to extents similar or greater than that of wt p53. Unexpectedly, p53Ala143 was defective in inducing apoptosis in H1299 cells at 32 degrees C. Concomitantly with the loss of apoptotic activity, p53Ala143 was found to be deficient in its ability to activate transcription from the p53-responsive portions of the Bax and insulin-like growth factor-binding protein 3 gene promoters. It is proposed that there may exist distinct classes of p53-responsive promoters, whose ability to be activated by p53 can be regulated differentially. Such differential regulation may have functional consequences for the effects of p53 on cell fate.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8756655      PMCID: PMC231498          DOI: 10.1128/MCB.16.9.4961

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  86 in total

1.  Functional domains and upstream activation properties of cloned human TATA binding protein.

Authors:  M G Peterson; N Tanese; B F Pugh; R Tjian
Journal:  Science       Date:  1990-06-29       Impact factor: 47.728

2.  Thymocyte apoptosis induced by p53-dependent and independent pathways.

Authors:  A R Clarke; C A Purdie; D J Harrison; R G Morris; C C Bird; M L Hooper; A H Wyllie
Journal:  Nature       Date:  1993-04-29       Impact factor: 49.962

3.  Wild-type mouse p53 down-regulates transcription from different virus enhancer/promoters.

Authors:  P Jackson; E Bos; A W Braithwaite
Journal:  Oncogene       Date:  1993-03       Impact factor: 9.867

4.  Essential role for p53-mediated transcription in E1A-induced apoptosis.

Authors:  P Sabbatini; J Lin; A J Levine; E White
Journal:  Genes Dev       Date:  1995-09-01       Impact factor: 11.361

5.  p53 binds single-stranded DNA ends through the C-terminal domain and internal DNA segments via the middle domain.

Authors:  G Bakalkin; G Selivanova; T Yakovleva; E Kiseleva; E Kashuba; K P Magnusson; L Szekely; G Klein; L Terenius; K G Wiman
Journal:  Nucleic Acids Res       Date:  1995-02-11       Impact factor: 16.971

Review 6.  Oncogenes and the strategy of growth factors.

Authors:  R Baserga
Journal:  Cell       Date:  1994-12-16       Impact factor: 41.582

7.  Wild-type p53 is a cell cycle checkpoint determinant following irradiation.

Authors:  S J Kuerbitz; B S Plunkett; W V Walsh; M B Kastan
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

8.  Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant.

Authors:  S Rowan; R L Ludwig; Y Haupt; S Bates; X Lu; M Oren; K H Vousden
Journal:  EMBO J       Date:  1996-02-15       Impact factor: 11.598

9.  Molecular cloning and functional analysis of Drosophila TAF110 reveal properties expected of coactivators.

Authors:  T Hoey; R O Weinzierl; G Gill; J L Chen; B D Dynlacht; R Tjian
Journal:  Cell       Date:  1993-01-29       Impact factor: 41.582

10.  p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest.

Authors:  V Dulić; W K Kaufmann; S J Wilson; T D Tlsty; E Lees; J W Harper; S J Elledge; S I Reed
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

View more
  60 in total

1.  Identification of partial loss of function p53 gene mutations utilizing a yeast-based functional assay.

Authors:  G K Kovvali; B Mehta; C B Epstein; S G Lutzker
Journal:  Nucleic Acids Res       Date:  2001-03-01       Impact factor: 16.971

2.  The involvement of p53 in dopamine-induced apoptosis of cerebellar granule neurons and leukemic cells overexpressing p53.

Authors:  D Daily; A Barzilai; D Offen; A Kamsler; E Melamed; I Ziv
Journal:  Cell Mol Neurobiol       Date:  1999-04       Impact factor: 5.046

Review 3.  Genetics, chemistry, and function of the IGF/IGFBP system.

Authors:  P F Collett-Solberg; P Cohen
Journal:  Endocrine       Date:  2000-04       Impact factor: 3.633

4.  TopBP1 mediates mutant p53 gain of function through NF-Y and p63/p73.

Authors:  Kang Liu; Shiyun Ling; Weei-Chin Lin
Journal:  Mol Cell Biol       Date:  2011-09-19       Impact factor: 4.272

5.  General transcriptional coactivator PC4 activates p53 function.

Authors:  Sourav Banerjee; B R Prashanth Kumar; Tapas K Kundu
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

6.  Disparate chromatin landscapes and kinetics of inactivation impact differential regulation of p53 target genes.

Authors:  Nathan P Gomes; Joaquín M Espinosa
Journal:  Cell Cycle       Date:  2010-09-13       Impact factor: 4.534

7.  Regulation of ES cell differentiation by functional and conformational modulation of p53.

Authors:  K Sabapathy; M Klemm; R Jaenisch; E F Wagner
Journal:  EMBO J       Date:  1997-10-15       Impact factor: 11.598

8.  Partial p53-dependence of anisomycin-induced apoptosis in PC12 cells.

Authors:  R Schipp; J Varga; J Bátor; M Vecsernyés; Z Árvai; M Pap; József Szeberényi
Journal:  Mol Cell Biochem       Date:  2017-04-21       Impact factor: 3.396

9.  NCF2/p67phox: A novel player in the anti-apoptotic functions of p53.

Authors:  Patricia A J Muller
Journal:  Cell Cycle       Date:  2012-12-19       Impact factor: 4.534

10.  The intrinsic radioresistance of glioblastoma-derived cell lines is associated with a failure of p53 to induce p21(BAX) expression.

Authors:  H K Shu; M M Kim; P Chen; F Furman; C M Julin; M A Israel
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.